Compounds > d-alpha tocopherol
Page last updated: 2024-08-21

d-alpha tocopherol and Parkinson Disease, Secondary

d-alpha tocopherol has been researched along with Parkinson Disease, Secondary in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caligiuri, MP; Lohr, JB1
Breteler, MM; de Rijk, MC; den Breeijen, JH; Grobbee, DE; Hofman, A; Launer, LJ; van der Meché, FG1
Beal, MF; Fontaine, D; Haas, RH; Nakano, K; Shults, CW1
Dorfman-Etrog, P; Hermesh, H; Munitz, H; Prilipko, L; Weizman, A1
Acuff, RV; Daigneault, EA; Gong, L; Kostrzewa, RM1

Trials

4 trial(s) available for d-alpha tocopherol and Parkinson Disease, Secondary

ArticleYear
Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Parkinson Study Group.
    Annals of neurology, 1996, Volume: 39, Issue:1

    Topics: Aged; Antioxidants; Antiparkinson Agents; Disabled Persons; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Selegiline; Treatment Outcome; Vitamin E

1996
Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group.
    Annals of neurology, 1996, Volume: 39, Issue:1

    Topics: Aged; Antioxidants; Antiparkinson Agents; Disabled Persons; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Selegiline; Treatment Outcome; Vitamin E

1996
A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:4

    Topics: Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Physical Examination; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Severity of Illness Index; Treatment Outcome; Vitamin E

1996
The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:6

    Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Parkinson Disease, Secondary; Schizophrenia; Vitamin E

1999

Other Studies

3 other study(ies) available for d-alpha tocopherol and Parkinson Disease, Secondary

ArticleYear
Dietary antioxidants and Parkinson disease. The Rotterdam Study.
    Archives of neurology, 1997, Volume: 54, Issue:6

    Topics: Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; beta Carotene; Cross-Sectional Studies; Diet; Female; Flavonoids; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Parkinson Disease, Secondary; Severity of Illness Index; Surveys and Questionnaires; Vitamin E

1997
Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients.
    Neurology, 1998, Volume: 50, Issue:3

    Topics: Absorption; Administration, Oral; Aged; Citrate (si)-Synthase; Coenzymes; Dose-Response Relationship, Drug; Drug Carriers; Female; Humans; Male; Middle Aged; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Parkinson Disease, Secondary; Pilot Projects; Severity of Illness Index; Ubiquinone; Vitamin E

1998
Vitamin E supplements fail to protect mice from acute MPTP neurotoxicity.
    Neuroreport, 1991, Volume: 2, Issue:9

    Topics: Animals; Corpus Striatum; Dopamine; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease, Secondary; Vitamin E

1991